Cumberland Pharmaceuticals Inc. (CPIX)
NASDAQ · Healthcare
Cumberland Pharmaceuticals Inc. Shareholder Equity 2009–2025
Cumberland Pharmaceuticals Inc. annual shareholder equity history from 2010 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Cumberland Pharmaceuticals Inc. shareholder equity as of December 31, 2025: 24.9M, a 8.87% increase year-over-year.
- Cumberland Pharmaceuticals Inc. shareholder equity for 2025 were 24.9M, a 8.87% increase from 2024.
- Cumberland Pharmaceuticals Inc. shareholder equity for 2024 were 22.9M, a 22.80% decrease from 2023.
- Cumberland Pharmaceuticals Inc. shareholder equity for 2023 were 29.6M, a 18.37% decrease from 2022.
- Cumberland Pharmaceuticals Inc. shareholder equity for 2022 were 36.3M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Cumberland Pharmaceuticals Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $25 |
| 2024 | $23 |
| 2023 | $30 |
| 2022 | $36 |
| 2021 | $43 |
| 2020 | $47 |
| 2019 | $51 |
| 2018 | $56 |
| 2017 | $64 |
| 2016 | $73 |
| 2015 | $77 |
| 2014 | $81 |
| 2013 | $79 |
| 2012 | $86 |
| 2011 | $83 |
Cumberland Pharmaceuticals Inc. Shareholder Equity — FAQ
Cumberland Pharmaceuticals Inc. (CPIX) shareholder equity over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CPIX's shareholder equity history?
The chart and table above show Cumberland Pharmaceuticals Inc.'s shareholder equity by year and by quarter, including the growth rate.